STVN
Stevanato Group SpA
NYSE · Healthcare · Medical - Instruments & Supplies · IT
$19.02
+0.63%Forward multiples
Based on analyst estimates
- P/E forward
- 24.66x
- P/E 2026E
- 27.38x
- P/E 2027E
- 22.94x
- P/E 2028E
- 19.52x
- P/S forward
- 3.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- 35.32x
- PEG TTM
- 0.80x
- Price / book
- 2.99x
- Price / sales
- 3.79x
- Price / cash flow
- 18.75x
Enterprise value
- Enterprise value
- $5.6B
- EV / sales
- 4.08x
- EV / EBITDA
- 16.84x
- EV / EBIT
- 25.39x
- Market cap
- $5.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026